A Network-Based Embedding Method for Drug-Target Interaction Prediction

Integration of multi-omics and pharmacological data can help researchers understand the impact of drugs on dynamic biological systems. Network-based approaches to such integration explore the interaction of different cellular components and drugs. However, with ever-increasing amounts of data, processing these high-dimensional biological networks requires powerful tools. We investigate whether network embeddings can address this problem by providing an effective method for dimensionality reduction in drug-related networks. A neural network-based embedding method is employed to encode protein-protein, protein-disease, drug-drug and drug-disease networks for the prediction of novel drug-target interactions. We found that drug-target interaction prediction using embeddings of heterogeneous networks as input features performs comparably to state-of-the-art methods, exhibiting an area under the ROC curve of 84%, outperforming methods such as BLM-NII and NetLapRLS, and coming very close to the best performing network methods such as HNM, CMF and DTINet. These encouraging results suggest that further investigation of this approach is warranted.

[1]  Yoshihiro Yamanishi,et al.  Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..

[2]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[3]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..

[4]  Stefano Moro,et al.  Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview , 2018, Front. Pharmacol..

[5]  Inderjit S. Dhillon,et al.  Provable Inductive Matrix Completion , 2013, ArXiv.

[6]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[7]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[8]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[9]  Bonnie Berger,et al.  Diffusion Component Analysis: Unraveling Functional Topology in Biological Networks , 2015, RECOMB.

[10]  Roded Sharan,et al.  To Embed or Not: Network Embedding as a Paradigm in Computational Biology , 2019, Front. Genet..

[11]  Xiaobo Zhou,et al.  Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.

[12]  Jian Peng,et al.  A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information , 2017, Nature Communications.

[13]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[14]  Inderjit S. Dhillon,et al.  Large-scale Multi-label Learning with Missing Labels , 2013, ICML.

[15]  Christos Faloutsos,et al.  Fast Random Walk with Restart and Its Applications , 2006, Sixth International Conference on Data Mining (ICDM'06).

[16]  Subhash C Basak,et al.  Chemobioinformatics: the advancing frontier of computer-aided drug design in the post-genomic era. , 2012, Current computer-aided drug design.

[17]  Joos Vandewalle,et al.  A Multilinear Singular Value Decomposition , 2000, SIAM J. Matrix Anal. Appl..

[18]  Xiang Zhang,et al.  Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..

[19]  Hugo Kubinyi,et al.  Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective , 2004 .

[20]  Koki Tsuyuzaki,et al.  Biological Systems as Heterogeneous Information Networks: A Mini-review and Perspectives , 2017, ArXiv.

[21]  Hao Ding,et al.  Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.

[22]  Jeffrey Dean,et al.  Efficient Estimation of Word Representations in Vector Space , 2013, ICLR.

[23]  Xiangrong Liu,et al.  Machine Learning for Drug-Target Interaction Prediction , 2018, Molecules.

[24]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[25]  Jian Peng,et al.  A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information , 2017, RECOMB 2017.

[26]  S. Dibyajyoti,et al.  Bioinformatics:The effects on the cost of drug discovery , 2013 .

[27]  Jure Leskovec,et al.  node2vec: Scalable Feature Learning for Networks , 2016, KDD.

[28]  Niroshini Nirmalan,et al.  “Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives , 2016, Proteomes.